Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

PDF Survey Finds Patient Input is Critical to Guiding Parkinson’s Research

Data Presented at 19th Annual International Parkinson and Movement Disorders Society Congress in San Diego, CA - Jun 15 2015

Insights from the patient community are critical to guiding scientific research toward unmet needs in Parkinson’s disease (PD), according to the Parkinson’s Disease Foundation. These findings were presented in a poster titled, “Engaging people with Parkinson’s in determining and defining research priorities: The PDF Community Choice Research Awards,” (poster #311), on Monday, June 15 at the 19th International Parkinson and Movement Disorders Society Congress.

“We found that engaging people with Parkinson’s and their care partners in determining research priorities can help us identify unmet needs that warrant attention by scientists,” said lead authorVeronica Todaro, M.P.H., Vice President, National Programs, Parkinson’s Disease Foundation.

The poster looked first at responses from 304 individuals in the patient community who took an online questionnaire for the PDF Community Choice Research Awards in 2013. Of the respondents, 62 percent were female and 35 were male (3 percent chose not to answer). Additionally, 69 percent identified as a person living with Parkinson’s and 23 percent identified as a care partner.

Respondents shared information about which research question in Parkinson’s was most pressing to them. Answers were far reaching, but could be categorized into five general areas: therapies, living with PD, clinical understanding, basic science and genetics/risks. Unsurprisingly, therapies represented the topic area within which the greatest number of responses could be categorized. Ultimately two issues, fatigue (living with Parkinson’s) and gastrointestinal dysfunction (clinical understanding), were selected by PDF reviewers for funding.

PDF supported two conferences to discuss the two patient-chosen research areas (fatigue and gastrointestinal dysfunction) and surveyed 19 research professionals who attended alongside patient representatives. Of those attendees surveyed (n=19), the majority, 95 percent, indicated that patient input enriched the meeting, while 68 percent stated that the experience made them more inclined to include patients in future scientific conversations.

"The PDF Community Choice Awards has brought patient engagement to the next level. As people with Parkinson’s disease, we merit a voice in the decision-making and PDF has opened the doors to allow that with the Community Choice Awards. I know that this input, all from the community, will be invaluable to scientists as they consider research priorities," said Karen Smith, Vice Chair, People with Parkinson's Advisory Council.

Monday, June 15, 2015
In Memory of Robert Traurig
Wednesday, July 18, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member Robert (Bob) Traurig. From 2004 to 2015, he was a member of the Foundation’s board of directors. Bob is survived by his wife Jacqueline, his daughters Madeline Sackel and Wendy Traurig.

New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.


mail icon

Subscribe to get the latest news on treatments, research and other updates.